香港股市 已收市

MRK Jan 2026 135.000 put

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
25.650.00 (0.00%)
市場開市。 截至 09:54AM EDT。
全螢幕
前收市價25.65
開市25.65
買盤19.15
賣出價21.00
拍板135.00
到期日2026-01-16
今日波幅25.65 - 25.65
合同範圍
成交量590
未平倉合約453
  • Benzinga

    Pfizer Advances On Its Cancer Journey

    On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024 Congress. Affecting as many as 9 million people across the globe, cancer cachexia is a life-threatening condition that causes cancer patients to lose appetite and consequently, weight. Paving The Way For The World’s First Treatment For Cancer Cachexia The mid-stage trial results showed that patients that

  • Zacks

    Merck's Keytruda Obtains its First FDA Approval for Mesothelioma

    The FDA approves MRK's Keytruda for first-line treatment of malignant pleural mesothelioma. This marks Keytruda's first approval for the given indication.

  • Zacks

    Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know

    Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.